142 related articles for article (PubMed ID: 31897150)
1. Activity and mechanism of flavokawain A in inhibiting P-glycoprotein expression in paclitaxel resistance of lung cancer.
Li J; Zheng L; Yan M; Wu J; Liu Y; Tian X; Jiang W; Zhang L; Wang R
Oncol Lett; 2020 Jan; 19(1):379-387. PubMed ID: 31897150
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Combination of Sodium Aescinate-Stabilized, Polymer-Free, Twin-Like Nanoparticles to Reverse Paclitaxel Resistance.
Li J; Zheng L; Wang R; Sun D; Liang S; Wu J; Liu Y; Tian X; Li T; Yang Y; Han L
Int J Nanomedicine; 2020; 15():5839-5853. PubMed ID: 32848393
[TBL] [Abstract][Full Text] [Related]
3. FKA-A NPs enhances PTX-A NPs efficacy to suppress ovarian cancer via regulating Skp2/YAP pathway.
Li J; Wang R; Liu Y; Wu Y; Han L; Zheng L; Bao Z
Fundam Clin Pharmacol; 2023 Feb; 37(1):125-136. PubMed ID: 36028983
[TBL] [Abstract][Full Text] [Related]
4. Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations.
Niu L; Ding L; Lu C; Zuo F; Yao K; Xu S; Li W; Yang D; Xu X
J Ethnopharmacol; 2016 Sep; 191():350-359. PubMed ID: 27318274
[TBL] [Abstract][Full Text] [Related]
5. Dietary feeding of Flavokawain A, a Kava chalcone, exhibits a satisfactory safety profile and its association with enhancement of phase II enzymes in mice.
Li X; Xu X; Ji T; Liu Z; Gu M; Hoang BH; Zi X
Toxicol Rep; 2014; 1():2-11. PubMed ID: 25379458
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.
Li C; Zhao X; Yang Y; Liu S; Liu Y; Li X
Med Sci Monit; 2018 May; 24():2750-2757. PubMed ID: 29723165
[TBL] [Abstract][Full Text] [Related]
7. Flavokawain A ameliorates pulmonary fibrosis by inhibiting the TGF-β signaling pathway and CXCL12/CXCR4 axis.
Xiao T; Gao D; Gu X; Zhang Y; Zhu Y; Zhang Z; He Y; Wei L; Li H; Zhou H; Yang C
Eur J Pharmacol; 2023 Nov; 958():175981. PubMed ID: 37579968
[TBL] [Abstract][Full Text] [Related]
8. Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model.
Liu Z; Xu X; Li X; Liu S; Simoneau AR; He F; Wu XR; Zi X
Cancer Prev Res (Phila); 2013 Dec; 6(12):1365-75. PubMed ID: 24121102
[TBL] [Abstract][Full Text] [Related]
9. Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter.
Zhang Q; Song Y; Cheng X; Xu Z; Matthew OA; Wang J; Sun Z; Zhang X
Anticancer Res; 2019 Oct; 39(10):5461-5471. PubMed ID: 31570440
[TBL] [Abstract][Full Text] [Related]
10. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
[TBL] [Abstract][Full Text] [Related]
11. Flavokawain A alleviates the progression of mouse osteoarthritis: An
Jing S; Wan J; Wang T; He Z; Ding Q; Sheng G; Wang S; Zhao H; Zhu Z; Wu H; Li W
Front Bioeng Biotechnol; 2022; 10():1071776. PubMed ID: 36545678
[TBL] [Abstract][Full Text] [Related]
12. Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation.
Wang Z; Yin J; Li M; Shen J; Xiao Z; Zhao Y; Huang C; Zhang H; Zhang Z; Cho CH; Wu X
Chin Med; 2019; 14():7. PubMed ID: 30911326
[TBL] [Abstract][Full Text] [Related]
13. Nobiletin potentiates paclitaxel anticancer efficacy in A549/T xenograft model: Pharmacokinetic and pharmacological study.
Feng SL; Tian Y; Huo S; Qu B; Liu RM; Xu P; Li YZ; Xie Y
Phytomedicine; 2020 Feb; 67():153141. PubMed ID: 31884406
[TBL] [Abstract][Full Text] [Related]
14. Flavokawain A inhibits prostate cancer cells by inducing cell cycle arrest and cell apoptosis and regulating the glutamine metabolism pathway.
Wang K; Zhang W; Wang Z; Gao M; Wang X; Han W; Zhang N; Xu X
J Pharm Biomed Anal; 2020 Jul; 186():113288. PubMed ID: 32361091
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of Urothelial Cell Carcinoma Tumorigenesis by Dietary Flavokawain A in UPII-Mutant Ha-ras Transgenic Mice.
Liu Z; Song L; Xie J; Simoneau AR; Uchio E; Zi X
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335874
[TBL] [Abstract][Full Text] [Related]
16. Flavokawain A Reduces Tumor-Initiating Properties and Stemness of Prostate Cancer.
Song L; Mino M; Yamak J; Nguyen V; Lopez D; Pham V; Fazelpour A; Le V; Fu D; Tippin M; Uchio E; Zi X
Front Oncol; 2022; 12():943846. PubMed ID: 35912174
[TBL] [Abstract][Full Text] [Related]
17. Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model.
Li X; Yokoyama NN; Zhang S; Ding L; Liu HM; Lilly MB; Mercola D; Zi X
Oncotarget; 2015 Dec; 6(39):41809-24. PubMed ID: 26497688
[TBL] [Abstract][Full Text] [Related]
18. Guajadial reverses multidrug resistance by inhibiting ABC transporter expression and suppressing the PI3K/Akt pathway in drug-resistant breast cancer cells.
Li Y; Zhai Z; Li H; Wang X; Huang Y; Su X
Chem Biol Interact; 2019 May; 305():98-104. PubMed ID: 30929998
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway.
Zhang W; Cai J; Chen S; Zheng X; Hu S; Dong W; Lu J; Xing J; Dong Y
Mol Med Rep; 2015 Jul; 12(1):1506-14. PubMed ID: 25760096
[TBL] [Abstract][Full Text] [Related]
20. Overcoming drug-resistant lung cancer by paclitaxel loaded tetrahedral DNA nanostructures.
Xie X; Shao X; Ma W; Zhao D; Shi S; Li Q; Lin Y
Nanoscale; 2018 Mar; 10(12):5457-5465. PubMed ID: 29484330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
